1. PET/SPECT imaging agents for neurodegenerative diseases;Zhu;Chem Soc Rev,2014
2. Zhang L, Chang RC, Chu LW and Mak HK. Current neuroimaging techniques in Alzheimer’s disease and applications in animal models. Am J Nucl Med Mol Imaging 2012; 2: 386-404.
3. SPECT and PET imaging in Alzheimer’s disease;Valotassiou;Ann Nucl Med,2018
4. Filippi L, Chiaravalloti A, Bagni O and Schillaci O. 18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer’s disease. Am J Nucl Med Mol Imaging 2018; 8: 268-281.
5. Considerations in the development of reversibly binding PET radioligands for brain imaging;Pike;Curr Med Chem,2016